Literature DB >> 19107448

Racial differences in clinical outcome after prostate cancer treatment.

Takashi Fukagai1, Thomas Namiki, Robert G Carlile, Mikio Namiki.   

Abstract

Prostate cancer is the number one killer in the United States. A comparison of US and Japanese population is discussed in this chapter to identify risk factors for prostate cancer. Screening of prostate cancer is common among Americans, but not among Japanese. A comparison of survival in different populations is also presented; and prognosis after hormonal treatment in different populations is included.

Entities:  

Mesh：

Year:  2009        PMID： 19107448     DOI： 10.1007/978-1-60327-492-0_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  7 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

2.  Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer.

Authors:  Takashi Mizowaki; Yoshiki Norihisa; Kenji Takayama; Itaru Ikeda; Haruo Inokuchi; Kiyonao Nakamura; Tomomi Kamba; Takahiro Inoue; Toshiyuki Kamoto; Osamu Ogawa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2016-02-03       Impact factor: 3.402

3.  Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis.

Authors:  Masahiro Nozawa; Takeshi Inagaki; Kazuhiro Nagao; Tsukasa Nishioka; Takahiro Komura; Atsunobu Esa; Michio Kitagawa; Masaaki Imanishi; Yasunari Uekado; Takatoshi Ogawa; Hiroshi Kajikawa; Shigeya Uejima; Hideyasu Matsuyama; Isao Hara; Hirotsugu Uemura
Journal:  Int J Clin Oncol       Date:  2013-08-03       Impact factor: 3.402

Review 4.  Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.

Authors:  Yasuhide Kitagawa; Mikio Namiki
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

5.  Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups.

Authors:  Naif Zaman; Paresa N Giannopoulos; Shafinaz Chowdhury; Eric Bonneil; Pierre Thibault; Edwin Wang; Mark Trifiro; Miltiadis Paliouras
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

Review 6.  Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.

Authors:  Katalin Balázs; Lilla Antal; Géza Sáfrány; Katalin Lumniczky
Journal:  J Pers Med       Date:  2021-04-13

Review 7.  Prostate cancer in East Asia: evolving trend over the last decade.

Authors:  Yao Zhu; Hong-Kai Wang; Yuan-Yuan Qu; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.